Zimmerman TM - Search Results

1

Clinical impact of ex vivo differentiated myeloid precursors after high-dose chemotherapy and peripheral blood progenitor cell rescue.

Zimmerman TM, Lee WJ, Bender JG, Schilling M, Smith SL, Van Epps DE, Williams SF. Zimmerman TM, et al. Bone Marrow Transplant. 2000 Sep;26(5):505-10. doi: 10.1038/sj.bmt.1702543. Bone Marrow Transplant. 2000. PMID: 11019839

2

CD34 may be used to determine the adequacy of a stem cell harvest for hematologic recovery following high dose chemotherapy.

Zimmerman TM, Lee WJ, Bender JG, Mick R, Williams SF. Zimmerman TM, et al. Prog Clin Biol Res. 1994;389:303-8. Prog Clin Biol Res. 1994. PMID: 7535435 No abstract available.

3

Quantitative CD34 analysis may be used to guide peripheral blood stem cell harvests.

Zimmerman TM, Lee WJ, Bender JG, Mick R, Williams SF. Zimmerman TM, et al. Bone Marrow Transplant. 1995 Mar;15(3):439-44. Bone Marrow Transplant. 1995. PMID: 7541269 Clinical Trial.

4

Source of stem cells impacts on hematopoietic recovery after high-dose chemotherapy.

Zimmerman TM, Mick R, Myers S, Bender JG, Lee WJ, Williams SF. Zimmerman TM, et al. Bone Marrow Transplant. 1995 Jun;15(6):923-7. Bone Marrow Transplant. 1995. PMID: 7581092 Review.

5

Large-scale selection of CD34+ peripheral blood progenitors and expansion of neutrophil precursors for clinical applications.

Zimmerman TM, Bender JG, Lee WJ, Loudovaris M, Qiao X, Schilling M, Smith SL, Unverzagt K, Van Epps DE, Blake M, Williams DF, Williams SF. Zimmerman TM, et al. J Hematother. 1996 Jun;5(3):247-53. doi: 10.1089/scd.1.1996.5.247. J Hematother. 1996. PMID: 8817391

6

Clinical use of selected and expanded peripheral blood CD34+ cells: a preliminary report of feasibility and safety.

Zimmerman TM, Williams SF, Bender JG, Lee WJ, Blake M, Carreon J, Swinney P, Smith SJ, Schilling M, Oldham F, et al. Zimmerman TM, et al. J Hematother. 1995 Dec;4(6):527-9. doi: 10.1089/scd.1.1995.4.527. J Hematother. 1995. PMID: 8846012

7

A Phase I dose escalation trial of continuous infusion paclitaxel to augment high dose cyclophosphamide and thiotepa plus stem cell rescue for the treatment of patients with advanced breast carcinoma.

Zimmerman TM, Grinblatt DL, Malloy R, Williams SF. Zimmerman TM, et al. Cancer. 1998 Oct 15;83(8):1540-5. Cancer. 1998. PMID: 9781947 Clinical Trial.

8

Clinical applications of ex vivo cultured CD34+ cells and myeloid progenitors.

Zimmerman TM, Williams SF. Zimmerman TM, et al. Cytokines Cell Mol Ther. 1998 Dec;4(4):257-64. Cytokines Cell Mol Ther. 1998. PMID: 10068059 Review.

9

A phase II trial of docetaxel for peripheral blood stem cell mobilization for patients with breast cancer and ovarian cancer.

Laport GG, Fleming GF, Waggoner S, Zimmerman TM, Grinblatt DL, Williams SF. Laport GG, et al. Among authors: zimmerman tm. Bone Marrow Transplant. 2001 Apr;27(7):677-81. doi: 10.1038/sj.bmt.1702861. Bone Marrow Transplant. 2001. PMID: 11360105 Clinical Trial.

10

Source of stem cell rescue: bone marrow versus peripheral blood progenitors.

Williams SF, Zimmerman T, Grad G, Mick R. Williams SF, et al. J Hematother. 1993 Winter;2(4):521-3. doi: 10.1089/scd.1.1993.2.521. J Hematother. 1993. PMID: 7522110 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

51 results

Search Page

Filters